Avient (AVNT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Nov, 2025Executive summary
Achieved fourth consecutive quarter of organic growth, with Q1 2025 organic sales up 2% year-over-year, driven by packaging and healthcare, while transportation and defense lagged.
Adjusted EPS was $0.76, up 4% year-over-year excluding FX, and in line with guidance; GAAP EPS was ($0.22) due to special items, including an $86.3 million ERP impairment.
Adjusted EBITDA margin expanded by 20 basis points to 17.5% due to favorable mix and cost discipline.
Net loss attributable to common shareholders was $20.2 million, compared to net income of $49.4 million in Q1 2024, mainly due to the ERP impairment.
Organic sales growth achieved despite macroeconomic volatility and weak U.S. consumer and transportation demand.
Financial highlights
Q1 2025 sales were $826.6 million, down 0.3% as reported but up 2% organically year-over-year, with adjusted EBITDA of $144.7 million, up 4% organically.
Adjusted EPS was $0.76, flat year-over-year, with prior-year Q1 having grown 21% over Q1 2023.
Gross margin (GAAP) was 31.8%, down from 33.6% year-over-year; adjusted gross margin was 32.8% of sales.
Net cash used by operating activities was $51.1 million, up from $42.8 million in Q1 2024, reflecting higher incentive compensation and working capital needs.
Cash and cash equivalents at quarter-end were $456.0 million; total liquidity including revolver availability was $711.1 million.
Outlook and guidance
Full-year 2025 adjusted EPS guidance remains $2.70–$2.94; adjusted EBITDA guidance unchanged at $540–$570 million.
Q2 2025 adjusted EPS expected at $0.79, representing 4% growth year-over-year.
Company plans to pay down $100–$200 million of debt by year-end, supported by strong cash position and free cash flow expectations.
Guidance range unchanged despite increased macro uncertainty; scenarios modeled for flat to mid-single digit growth or declines in the second half.
Ongoing restructuring and integration of Clariant Color expected to complete by end of 2025, with $70 million in total charges anticipated.
Latest events from Avient
- Q2 2026 saw record margin, 20% EPS growth, and raised guidance on strong sales and cash flow.AVNT
Q2 2026 - Margin expansion, innovation, and disciplined growth drive strong 2026 outlook.AVNT
Investor presentation - 2026 guidance projects higher margins and EPS, driven by innovation and strong execution.AVNT
Investor presentation - All voting items passed as 2025 financial targets were met and strategic growth plans outlined.AVNT
AGM 2026 - Strong margin expansion and growth guidance driven by innovation and disciplined execution.AVNT
Investor presentation - Q1 2026 adjusted EPS rose 9% to $0.83, with sales up and margins expanding.AVNT
Q1 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.AVNT
Proxy filing - 2026 proxy details innovation-driven strategy, board refresh, and performance-based executive pay.AVNT
Proxy filing - 2025 delivered record margins and EPS growth; 2026 guidance targets further gains amid volatility.AVNT
Q4 2025 - Q3 sales and earnings rose sharply, with guidance and dividend both increased.AVNT
Q3 2024